Filter News
Area of Research
- Biology and Environment (13)
- Clean Energy (11)
- Computational Biology (1)
- Computational Engineering (1)
- Fusion and Fission (5)
- Fusion Energy (4)
- Isotopes (3)
- Materials (13)
- Materials for Computing (6)
- National Security (1)
- Neutron Science (12)
- Nuclear Science and Technology (7)
- Nuclear Systems Modeling, Simulation and Validation (1)
- Quantum information Science (2)
- Supercomputing (26)
News Type
News Topics
- (-) Advanced Reactors (15)
- (-) Biomedical (31)
- (-) Frontier (5)
- (-) Microscopy (18)
- (-) Summit (26)
- 3-D Printing/Advanced Manufacturing (49)
- Artificial Intelligence (15)
- Big Data (13)
- Bioenergy (25)
- Biology (28)
- Biotechnology (7)
- Buildings (11)
- Chemical Sciences (12)
- Clean Water (10)
- Climate Change (20)
- Composites (7)
- Computer Science (68)
- Coronavirus (32)
- Critical Materials (6)
- Cybersecurity (8)
- Decarbonization (6)
- Energy Storage (40)
- Environment (61)
- Exascale Computing (5)
- Fusion (21)
- Grid (16)
- High-Performance Computing (22)
- Isotopes (20)
- ITER (4)
- Machine Learning (9)
- Materials (33)
- Materials Science (57)
- Mathematics (3)
- Mercury (4)
- Molten Salt (2)
- Nanotechnology (26)
- National Security (9)
- Net Zero (1)
- Neutron Science (44)
- Nuclear Energy (36)
- Physics (16)
- Polymers (12)
- Quantum Computing (5)
- Quantum Science (24)
- Security (6)
- Space Exploration (6)
- Statistics (1)
- Sustainable Energy (56)
- Transformational Challenge Reactor (5)
- Transportation (32)
Media Contacts
Rich Giannone uses bioanalytical mass spectrometry to examine proteins, the primary driver in biological systems.
When COVID-19 was declared a pandemic in March 2020, Oak Ridge National Laboratory’s Parans Paranthaman suddenly found himself working from home like millions of others.
The Accelerating Therapeutics for Opportunities in Medicine , or ATOM, consortium today announced the U.S. Department of Energy’s Oak Ridge, Argonne and Brookhaven national laboratories are joining the consortium to further develop ATOM’s artificial intelligence, or AI-driven, drug discovery platform.
A rare isotope in high demand for treating cancer is now more available to pharmaceutical companies developing and testing new drugs.
Scientists have found new, unexpected behaviors when SARS-CoV-2 – the virus that causes COVID-19 – encounters drugs known as inhibitors, which bind to certain components of the virus and block its ability to reproduce.
Thirty-two Oak Ridge National Laboratory employees were named among teams recognized by former DOE Secretary Dan Brouillette with Secretary’s Honor Awards as he completed his term. Four teams received new awards that reflect DOE responses to the coronavirus pandemic.
Since the 1930s, scientists have been using particle accelerators to gain insights into the structure of matter and the laws of physics that govern our world.
Oak Ridge National Laboratory’s Center for Nanophase Materials Sciences contributed to a groundbreaking experiment published in Science that tracks the real-time transport of individual molecules.
In the quest for advanced vehicles with higher energy efficiency and ultra-low emissions, ORNL researchers are accelerating a research engine that gives scientists and engineers an unprecedented view inside the atomic-level workings of combustion engines in real time.
Oak Ridge National Laboratory and collaborators have discovered that signaling molecules known to trigger symbiosis between plants and soil bacteria are also used by almost all fungi as chemical signals to communicate with each other.